Time to Return of Bowel Function Following Perioperative Probiotics in Colorectal Cancer Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-99
SponsorNational University Hospital, Singapore

About this trial

There is pre-existing evidence that probiotics could be useful in the improvement of ileus rates. One metaanalysis of 30 studies demonstrated a reduction in the prevalence of post-operative ileus as determined by time to flatus, time to defecation, as well as postoperative abdominal distension (PMID:37373843). More broadly in gastrointestinal surgery, a meta-analysis of 21 randomised controlled trials similarly affirmed the speedier recovery of gastrointestinal function after surgery when probiotics were administered (PMID: 35231076). In spite of these advantages, the routine use of probiotics perioperatively for colorectal cancer surgery is not performed in Singapore. We therefore seek to perform a trial to investigate whether probiotic administration perioperatively may reduce post operative ileus rates.

Eligibility criteria

Qualifiers

undergoing elective colorectal cancer surgery in which an oncologic resection is planned

age between 21 and 99 years at the time of consent

willing to consider oral nutritional supplementation

on an early recovery after surgery (ERAS) pathway

Disqualifiers

patients with known contraindications to probiotic use

patients undergoing emergency surgery

taking any other form of probiotics

taking oral antibiotics within 7 days of commencement of study

Trial design

Treatments tested in this trial

  • Nestle Isocal
  • Nestle Boost Optimum

Treatment groups

162 Participants
are divided into 3 treatment groups